Detection of low frequency artemisinin resistance mutations, C469Y, P553L and A675V, and fixed antifolate resistance mutations in asymptomatic primary school children in Kenya

Abstract Background To understand the emergence and spread of drug-resistant parasites in malaria-endemic areas, accurate assessment and monitoring of antimalarial drug resistance markers is critical. Recent advances in next-generation sequencing (NGS) technologies have enabled the tracking of drug-...

Full description

Saved in:
Bibliographic Details
Main Authors: Victor Osoti, Kevin Wamae, Leonard Ndwiga, Paul M. Gichuki, Collins Okoyo, Stella Kepha, Kibor Keitany, Regina Kandie, Stephen Aricha, Rosebella Kiplagat, Charles Mwandawiro, Philip Bejon, Robert W. Snow, Lynette Isabella Ochola-Oyier
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Infectious Diseases
Subjects:
Online Access:https://doi.org/10.1186/s12879-025-10462-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832595006972493824
author Victor Osoti
Kevin Wamae
Leonard Ndwiga
Paul M. Gichuki
Collins Okoyo
Stella Kepha
Kibor Keitany
Regina Kandie
Stephen Aricha
Rosebella Kiplagat
Charles Mwandawiro
Philip Bejon
Robert W. Snow
Lynette Isabella Ochola-Oyier
author_facet Victor Osoti
Kevin Wamae
Leonard Ndwiga
Paul M. Gichuki
Collins Okoyo
Stella Kepha
Kibor Keitany
Regina Kandie
Stephen Aricha
Rosebella Kiplagat
Charles Mwandawiro
Philip Bejon
Robert W. Snow
Lynette Isabella Ochola-Oyier
author_sort Victor Osoti
collection DOAJ
description Abstract Background To understand the emergence and spread of drug-resistant parasites in malaria-endemic areas, accurate assessment and monitoring of antimalarial drug resistance markers is critical. Recent advances in next-generation sequencing (NGS) technologies have enabled the tracking of drug-resistant malaria parasites. Methods In this study, we used Targeted Amplicon Deep Sequencing (TADS) to characterise the genetic diversity of the Pfk13, Pfdhfr, Pfdhps, and Pfmdr1 genes among primary school-going children in 15 counties in Kenya (Bungoma, Busia, Homa Bay, Migori, Kakamega, Kilifi, Kirinyaga, Kisii, Kisumu, Kwale, Siaya, Tana River, Turkana, Vihiga and West Pokot). A total of 920 dried blood spot (DBS) samples collected from 121 selected primary schools within the country were used to extract genomic DNA. A nested polymerase chain reaction (PCR) was used to generate amplicons that were sequenced to determine the prevalence of known and novel polymorphisms. Results Pfk13 mutations associated with artemisinin resistance were present as mixed genotype infections for the C469Y mutation in 23 samples (4%), the A675V mutation in 2 samples (1.7%), and the P553L mutation in 7 samples (1.2%). The A578S mutation, was also identified in mixed infections, appearing in 15.2% of the 87 samples analysed. The Pfdhfr 51I and 108 N pyrimethamine-resistance mutations were at fixation (100% frequency), and the Pfmdr1 Y184F mutation, which is linked to reduced susceptibility to several antimalarial drugs, especially those used in combination therapies for malaria treatment, was detected in 97.5% of the samples as mixed-genotype infections. Conclusion The genomic surveillance of asymptomatic school children in Kenya provides an early warning signal of at least 1 of the 3 validated artemisinin resistance mutations circulating in all regions in Western Kenya sampled except Homa Bay and Kisii Counties. These signals in asymptomatic and mixed infections would have been missed without deep sequencing.
format Article
id doaj-art-dc0ebbf779df497ab06e550bfcb42bc8
institution Kabale University
issn 1471-2334
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series BMC Infectious Diseases
spelling doaj-art-dc0ebbf779df497ab06e550bfcb42bc82025-01-19T12:11:43ZengBMCBMC Infectious Diseases1471-23342025-01-0125111010.1186/s12879-025-10462-zDetection of low frequency artemisinin resistance mutations, C469Y, P553L and A675V, and fixed antifolate resistance mutations in asymptomatic primary school children in KenyaVictor Osoti0Kevin Wamae1Leonard Ndwiga2Paul M. Gichuki3Collins Okoyo4Stella Kepha5Kibor Keitany6Regina Kandie7Stephen Aricha8Rosebella Kiplagat9Charles Mwandawiro10Philip Bejon11Robert W. Snow12Lynette Isabella Ochola-Oyier13Centre for Geographic Medicine Research (Coast), Kenya Medical Research Institute-Wellcome Trust Research ProgrammeCentre for Geographic Medicine Research (Coast), Kenya Medical Research Institute-Wellcome Trust Research ProgrammeCentre for Geographic Medicine Research (Coast), Kenya Medical Research Institute-Wellcome Trust Research ProgrammeEastern and Southern Africa Centre of International Parasite Control, Kenya Medical Research InstituteEastern and Southern Africa Centre of International Parasite Control, Kenya Medical Research InstituteEastern and Southern Africa Centre of International Parasite Control, Kenya Medical Research InstituteDivision of National Malaria Programme, Ministry of HealthDivision of National Malaria Programme, Ministry of HealthDivision of National Malaria Programme, Ministry of HealthDivision of National Malaria Programme, Ministry of HealthEastern and Southern Africa Centre of International Parasite Control, Kenya Medical Research InstituteCentre for Geographic Medicine Research (Coast), Kenya Medical Research Institute-Wellcome Trust Research ProgrammeCentre for Geographic Medicine Research (Coast), Kenya Medical Research Institute-Wellcome Trust Research ProgrammeCentre for Geographic Medicine Research (Coast), Kenya Medical Research Institute-Wellcome Trust Research ProgrammeAbstract Background To understand the emergence and spread of drug-resistant parasites in malaria-endemic areas, accurate assessment and monitoring of antimalarial drug resistance markers is critical. Recent advances in next-generation sequencing (NGS) technologies have enabled the tracking of drug-resistant malaria parasites. Methods In this study, we used Targeted Amplicon Deep Sequencing (TADS) to characterise the genetic diversity of the Pfk13, Pfdhfr, Pfdhps, and Pfmdr1 genes among primary school-going children in 15 counties in Kenya (Bungoma, Busia, Homa Bay, Migori, Kakamega, Kilifi, Kirinyaga, Kisii, Kisumu, Kwale, Siaya, Tana River, Turkana, Vihiga and West Pokot). A total of 920 dried blood spot (DBS) samples collected from 121 selected primary schools within the country were used to extract genomic DNA. A nested polymerase chain reaction (PCR) was used to generate amplicons that were sequenced to determine the prevalence of known and novel polymorphisms. Results Pfk13 mutations associated with artemisinin resistance were present as mixed genotype infections for the C469Y mutation in 23 samples (4%), the A675V mutation in 2 samples (1.7%), and the P553L mutation in 7 samples (1.2%). The A578S mutation, was also identified in mixed infections, appearing in 15.2% of the 87 samples analysed. The Pfdhfr 51I and 108 N pyrimethamine-resistance mutations were at fixation (100% frequency), and the Pfmdr1 Y184F mutation, which is linked to reduced susceptibility to several antimalarial drugs, especially those used in combination therapies for malaria treatment, was detected in 97.5% of the samples as mixed-genotype infections. Conclusion The genomic surveillance of asymptomatic school children in Kenya provides an early warning signal of at least 1 of the 3 validated artemisinin resistance mutations circulating in all regions in Western Kenya sampled except Homa Bay and Kisii Counties. These signals in asymptomatic and mixed infections would have been missed without deep sequencing.https://doi.org/10.1186/s12879-025-10462-zPlasmodium FalciparumGenomic surveillanceAmplicon deep sequencingArtemisinin resistance
spellingShingle Victor Osoti
Kevin Wamae
Leonard Ndwiga
Paul M. Gichuki
Collins Okoyo
Stella Kepha
Kibor Keitany
Regina Kandie
Stephen Aricha
Rosebella Kiplagat
Charles Mwandawiro
Philip Bejon
Robert W. Snow
Lynette Isabella Ochola-Oyier
Detection of low frequency artemisinin resistance mutations, C469Y, P553L and A675V, and fixed antifolate resistance mutations in asymptomatic primary school children in Kenya
BMC Infectious Diseases
Plasmodium Falciparum
Genomic surveillance
Amplicon deep sequencing
Artemisinin resistance
title Detection of low frequency artemisinin resistance mutations, C469Y, P553L and A675V, and fixed antifolate resistance mutations in asymptomatic primary school children in Kenya
title_full Detection of low frequency artemisinin resistance mutations, C469Y, P553L and A675V, and fixed antifolate resistance mutations in asymptomatic primary school children in Kenya
title_fullStr Detection of low frequency artemisinin resistance mutations, C469Y, P553L and A675V, and fixed antifolate resistance mutations in asymptomatic primary school children in Kenya
title_full_unstemmed Detection of low frequency artemisinin resistance mutations, C469Y, P553L and A675V, and fixed antifolate resistance mutations in asymptomatic primary school children in Kenya
title_short Detection of low frequency artemisinin resistance mutations, C469Y, P553L and A675V, and fixed antifolate resistance mutations in asymptomatic primary school children in Kenya
title_sort detection of low frequency artemisinin resistance mutations c469y p553l and a675v and fixed antifolate resistance mutations in asymptomatic primary school children in kenya
topic Plasmodium Falciparum
Genomic surveillance
Amplicon deep sequencing
Artemisinin resistance
url https://doi.org/10.1186/s12879-025-10462-z
work_keys_str_mv AT victorosoti detectionoflowfrequencyartemisininresistancemutationsc469yp553landa675vandfixedantifolateresistancemutationsinasymptomaticprimaryschoolchildreninkenya
AT kevinwamae detectionoflowfrequencyartemisininresistancemutationsc469yp553landa675vandfixedantifolateresistancemutationsinasymptomaticprimaryschoolchildreninkenya
AT leonardndwiga detectionoflowfrequencyartemisininresistancemutationsc469yp553landa675vandfixedantifolateresistancemutationsinasymptomaticprimaryschoolchildreninkenya
AT paulmgichuki detectionoflowfrequencyartemisininresistancemutationsc469yp553landa675vandfixedantifolateresistancemutationsinasymptomaticprimaryschoolchildreninkenya
AT collinsokoyo detectionoflowfrequencyartemisininresistancemutationsc469yp553landa675vandfixedantifolateresistancemutationsinasymptomaticprimaryschoolchildreninkenya
AT stellakepha detectionoflowfrequencyartemisininresistancemutationsc469yp553landa675vandfixedantifolateresistancemutationsinasymptomaticprimaryschoolchildreninkenya
AT kiborkeitany detectionoflowfrequencyartemisininresistancemutationsc469yp553landa675vandfixedantifolateresistancemutationsinasymptomaticprimaryschoolchildreninkenya
AT reginakandie detectionoflowfrequencyartemisininresistancemutationsc469yp553landa675vandfixedantifolateresistancemutationsinasymptomaticprimaryschoolchildreninkenya
AT stephenaricha detectionoflowfrequencyartemisininresistancemutationsc469yp553landa675vandfixedantifolateresistancemutationsinasymptomaticprimaryschoolchildreninkenya
AT rosebellakiplagat detectionoflowfrequencyartemisininresistancemutationsc469yp553landa675vandfixedantifolateresistancemutationsinasymptomaticprimaryschoolchildreninkenya
AT charlesmwandawiro detectionoflowfrequencyartemisininresistancemutationsc469yp553landa675vandfixedantifolateresistancemutationsinasymptomaticprimaryschoolchildreninkenya
AT philipbejon detectionoflowfrequencyartemisininresistancemutationsc469yp553landa675vandfixedantifolateresistancemutationsinasymptomaticprimaryschoolchildreninkenya
AT robertwsnow detectionoflowfrequencyartemisininresistancemutationsc469yp553landa675vandfixedantifolateresistancemutationsinasymptomaticprimaryschoolchildreninkenya
AT lynetteisabellaocholaoyier detectionoflowfrequencyartemisininresistancemutationsc469yp553landa675vandfixedantifolateresistancemutationsinasymptomaticprimaryschoolchildreninkenya